Saturday 17 October 2026 Export DRMA’s income statement to Excel — free account

Dermata Therapeutics, Inc.

In the quarter to June 2026, EPS grew 55.4% and free cash flow grew 9.99%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.86 0.05 −5.49%

Follow DRMA

Alert me

Market cap: $4.5M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(203.36%)	(194.20%)	(103.58%)	(183.89%)
ROA Full definition →		(150.49%)	(132.63%)	(81.31%)	(139.93%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(223.42%)	(121.45%)	(110.75%)	(242.40%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(9.10)	(8.38)	(2.15)	(2.00)
Free Cash Flow Full definition →		(9.34)	(7.76)	(8.30)	(8.03)
Other line items
Cash ROIC Full definition →		(108.32%)	(56.44%)	(62.16%)	(101.69%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Days of Inventory on Hand Full definition →		—	—	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		1.06	1.03	1.17	0.96
Depreciation/Fixed assets Full definition →		—	—	—	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(9.10)	(8.38)	(2.15)	(2.00)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly